Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00707616 · ClinicalTrials.gov registry record
Common Genetic Variation and Type 2 Diabetes
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 190
- Enrollment target
NCT00707616: Completed study, sponsored by Mayo Clinic.
NCT00707616 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 190 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00707616 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 190 participants
- Enrollment target
Study Summary
Type 2 diabetes is a common metabolic disorder arising from a complex interaction between genetic predisposition and the environment. The development of this disorder is preceded by impaired glucose tolerance and elevated fasting glucose which also carry adverse cardiovascular risk. To date a few common genetic variants have been reliably associated with predisposition to type 2 diabetes. However, it is uncertain how these genes interact to alter insulin secretion and insulin action prior to the development of type 2 diabetes. We propose to utilize an established population-based cohort to determine how common genetic variants associated with type 2 diabetes alter the response to an oral glucose challenge in people without overt type 2 diabetes. This will enable us to understand how common variants alone or in combination alter whole-body glucose physiology and predispose to type 2 diabetes.
Interventions
- OTHER Oral glucose tolerance test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2006-03 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00707616
The ClinicalTrials.gov registry entry for NCT00707616 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral glucose tolerance test is the first listed.
NCT00707616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00707616 about?
NCT00707616 is a clinical study titled "Common Genetic Variation and Type 2 Diabetes". Type 2 diabetes is a common metabolic disorder arising from a complex interaction between genetic predisposition and the environment. The development of this disorder is preceded by impaired glucose tolerance and elevated fasting glucose which also carry adverse cardiovascular risk. To date a few co...
What is the current status of trial NCT00707616?
This trial is currently completed. The enrollment target is 190 participants. The study started on 2006-03. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00707616?
The interventions under investigation include: Oral glucose tolerance test (OTHER).
Who is sponsoring clinical trial NCT00707616?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.